2010-02-03
JIM 2010
Multiplate exhibits at the JIM 2010 in Rome ...read more

2010-01-29
Article using Multiplate in Circulation
A study evaluating the influence of the Cytochrome 2C19*17 allelic variant on platelet aggregation and bleeding events was published on January 18 in Circulation. ...read more

2010-01-29
Functional HIT testing on the Multiplate
The first full paper describing the use of Multiplate for HIT testing was published in Thrombosis Research. ...read more

2009-11-26
Further evidence for excellent clinical predictivity of Multiplate
Multiplate better determines PCI patients at enhanced risk for stent thrombosis than flow cytometric VASP assay. ...read more

2009-12-21
Multiplate in 2009
2009 was a very successful year for Multiplate. 38% turnover growth, almost 200 new installations and 40 medline-listed publications document the wide acceptance of Multiplate in the scientific and clinical community. ...read more

Multiplate® - the new standard for platelet diagnostics

Introduced in 2005, Multiplate® is one of the most widely applied platelet aggregometers in Europe today. Using simple whole blood analysis and intuitive software, Multiplate® is easy to implement in routine laboratory and near patient environments. Multiplate® is the method of choice for many European and international centers and is regarded by many experts as the analyser best suited for the clinical monitoring of antiplatelet therapy.

Multiplate® - Innovation made in Germany

Multiplate® is

+ fast
1
0 minute test time
measures directly in whole blood
no need for centrifugation

+ standardized
ce marked instrument, reagents, test cells, wide range of dedicated reagents, widely applied instrument

+ cost effective
competitively priced instrument and analysis.

+ predictive

sensitive for aspirin, clopidogrel, IIb/IIIa antagonists, predictive for both transfusion requirements and thrombotic events*, positive experiences from a large number of clinical centers throughout Europe


*The largest study to date evaluating the clinical impact of clopidogrel resistance (n=1608) has shown that patients, stratified as inadequate responders according to Multiplate® analysis exhibited a 9.4 fold increased risk of stent thrombosis (Sibbing D et al. J Am Coll Cardiol 2008; 53(10):849-56). In a recent study Siller-Matula et al reported a superior predictivity for stent thrombosis for Multiplate
® compared to the flow-cytometric VASP test (Multiple Electrode Aggregometry better predicts stent thrombosis than the VASP assay. J Thromb Haemost. 2009 Nov 23). The predictivity of Multiplate® analysis has also been demonstrated in neuroradiology (Mueller-Schunk S et al, AJNR 2008;29(4):786-9). Several studies have also shown that Multiplate® analysis is predictive for transfusion requirements in cardiac surgery (Rahe-Meyer N et al, Acta Anaesthesiol Scand. 2009 Feb;53(2):168-75; Rahe-Meyer N et al. Anesth Analg. 2008 Dec;107(6):1791-7; Mengistu AM et al, J Cardiothorac Vasc Anesth. 2008 Feb;22(1):40-6).

 

 

 

 

 


 

 

choose country
Please choose your country